Why insider trading matters?

Numerous studies have examined whether there is evidence that U.S. insiders systematically trade on private information despite the legal deterrence. The consensus appears to be that insider purchases (but not sales) tend to be followed by positive abnormal stock price performance, particularly for small growth stocks.

- Prof. B. Espen Eckbo, Dartmouth College
Progyny, Inc. (PGNY)
Sector: Healthcare; Industry: Health Information Services

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions for employers in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2022-01-20 Payson Norman Director Sell 16,660 $39.28 $654,438 No
2022-01-13 Payson Norman Director Sell 16,660 $45.48 $757,662 No
2022-01-04 Schlanger David J Executive Chairman Sell 50,704 $51.17 $2,594,594 Yes
2022-01-04 Anevski Peter Chief Executive Officer Sell 21,400 $51.17 $1,094,994 No
2021-12-30 Payson Norman Director Sell 16,660 $51.87 $864,088 No
2022-01-01 Schlanger David J Executive Chairman Sell 73,095 $52.18 $3,814,097 Yes
2021-12-23 Payson Norman Director Sell 16,660 $51.08 $850,955 No
2021-12-16 Payson Norman Director Sell 16,660 $47.69 $794,467 No
2021-12-09 Payson Norman Director Sell 16,660 $50.23 $836,842 No
2024-11-23 Payson Norman Director Sell 16,660 $54.01 $899,793 No
2021-11-18 Payson Norman Director Sell 16,660 $61.16 $1,019,008 No
2021-11-11 Payson Norman Director Sell 16,660 $62.24 $1,036,893 No
2021-11-08 Livingston Mark S. Chief Financial Officer Sell 15,858 $65.61 $1,040,507 Yes
2021-11-08 Scott Cheryl Director Sell 2,000 $66.30 $132,600 No
2021-11-08 Bealer Jennifer EVP, General Counsel Sell 32,215 $65.66 $2,115,352 Yes
2021-11-03 Schlanger David J Chief Executive Officer Sell 50,000 $61.34 $3,067,236 Yes
2021-11-04 Payson Norman Director Sell 16,660 $61.26 $1,020,596 No
2021-11-02 Schlanger David J Chief Executive Officer Sell 100,000 $62.07 $6,206,770 Yes
2021-10-28 Payson Norman Director Sell 16,660 $60.44 $1,006,988 No
2021-10-25 Bealer Jennifer EVP, General Counsel Sell 2,688 $63.99 $171,995 Yes
2021-10-14 Payson Norman Director Sell 16,660 $58.39 $972,843 No
2021-10-07 Payson Norman Director Sell 16,660 $58.25 $970,428 No
2021-10-07 Anevski Peter President and COO Sell 39,918 $58.97 $2,354,018 Yes
2021-10-05 Anevski Peter President and COO Sell 82,500 $57.52 $4,745,605 Yes
2021-10-05 Schlanger David J Chief Executive Officer Sell 150,000 $57.52 $8,628,743 Yes
2021-09-30 Payson Norman Director Sell 16,660 $55.98 $932,675 No
2021-09-28 Anevski Peter President and COO Sell 110,000 $59.01 $6,491,629 Yes
2021-09-23 Payson Norman Director Sell 16,660 $62.42 $1,039,948 No
2021-09-02 Payson Norman Director Sell 16,660 $56.16 $935,558 No
2021-08-26 Payson Norman Director Sell 16,660 $51.55 $858,874 No

Insider Smart

Enphase Energy, Inc (ENPH) - ENPH was $10+ in 15Q1 then dropped to $2 and eventually went under $1. From 15Q4 to 17Q4 it built a 2-year-long base then BOOM! Stock went as high as $70 and likely will make a new high. Catch one or two moves like this you can retire early. One hint before the big move was that CEO and CFO were constantly accumulating, this kind of information is priceless.

Insider Smart

VBI Vaccines Inc (VBIV) - Since 10%-owner Perceptive Advisor LCC increased their holding in April, the stock have double the price. Impressive!